We are live on
!
Find out more
Ocular Therapeutix
OCUL
OCUL
249 hedge funds and large institutions have $2.33B invested in Ocular Therapeutix in 2025 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 104 increasing their positions, 60 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
195% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 20
127% more call options, than puts
Call options by funds: $47.8M | Put options by funds: $21M
73% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 60
15% more funds holding
Funds holding: 216 → 249 (+33)
6% more capital invested
Capital invested by funds: $2.2B → $2.33B (+$125M)
18.23% less ownership
Funds ownership: 108.15% → 89.93% (-18%)
36% less funds holding in top 10
Funds holding in top 10: 11 → 7 (-4)
Holders
249
Holders Change
+33
Holders Change %
+15.28%
% of All Funds
3.03%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.09%
New
59
Increased
104
Reduced
60
Closed
20
Calls
$47.8M
Puts
$21M
Net Calls
+$26.8M
Net Calls Change
+$15.5M
Top Buyers
| 1 |
BlackRock
New York
|
+$61.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.3M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$26.5M |
| 4 |
D.E. Shaw & Co
New York
|
+$12.6M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.4M |
Top Sellers
| 1 |
VA
VR Adviser
New York
|
-$71M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$46.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$43.5M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$39.2M |
| 5 |
Morgan Stanley
New York
|
-$19.3M |
